Targeted therapy in the present status and prospect of ovarian cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 577-580, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-419664
ABSTRACT
Despite multimodel chemotherapy after successful surgical cytoreduction for ovarian cancer,disease recurrence continues to be problematic.Therefore,exploring new treatment strategy has already become urgent matter of the moment. Biological targeted therapies have been studied to overcome chemotherapy resistance.The most promising one at this time is bevacizumab.Results from phase Ⅱ and phase Ⅲ trials were excited.Deeper understanding of biologic pathway in ovarian cancer,and more biologic targets undergoing clinical trial will develop a new world for the treatment of ovarian cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Cancer Research and Clinic
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS